Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Asthma

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 8 articles:
HTML format
Text format



Single Articles


    October 2017
  1. KUPCZYK M, Kuna P
    Authors' Reply to Yilmaz and Turk: "Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".
    Drugs. 2017 Oct 4. doi: 10.1007/s40265-017-0822.
    PubMed     Text format    


  2. YILMAZ I, Turk M
    Comment on: "Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".
    Drugs. 2017 Oct 4. doi: 10.1007/s40265-017-0821.
    PubMed     Text format    


    September 2017
  3. DOMINGO C
    Overlapping Effects of New Monoclonal Antibodies for Severe Asthma.
    Drugs. 2017 Sep 25. doi: 10.1007/s40265-017-0810.
    PubMed     Text format     Abstract available


    July 2017
  4. SHIRLEY M
    Dupilumab: First Global Approval.
    Drugs. 2017;77:1115-1121.
    PubMed     Text format     Abstract available


    June 2017
  5. KUPCZYK M, Kuna P
    Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.
    Drugs. 2017 Jun 13. doi: 10.1007/s40265-017-0777.
    PubMed     Text format     Abstract available


    April 2017
  6. DEEKS ED, Brusselle G
    Reslizumab in Eosinophilic Asthma: A Review.
    Drugs. 2017 Apr 18. doi: 10.1007/s40265-017-0740.
    PubMed     Text format     Abstract available


    June 2016
  7. BULKHI A, Tabatabaian F, Casale TB
    Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions.
    Drugs. 2016.
    PubMed     Text format     Abstract available


    May 2016
  8. MARKHAM A
    Reslizumab: First Global Approval.
    Drugs. 2016;76:907-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: